Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

NVNO - enVVeno Medical Corp

IEX Last Trade
2.82
-2.380   -84.397%

Share volume: 0
Last Updated: Tue 24 Dec 2024 06:22:28 PM CET
Surgical and Medical Instrument Manufacturing : 50.37%

PREVIOUS CLOSE
CHG
CHG%
$5.20
-2.38
-45.77%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
13.25%
1 Month
-17.06%
3 Months
-38.43%
6 Months
-45.77%
1 Year
-42.45%
2 Year
-38.02%
Key data
Stock price
$2.82
P/E Ratio 
0.00
DAY RANGE
$2.84 - $5.20
EPS 
$0.00
52 WEEK RANGE
$2.64 - $6.97
52 WEEK CHANGE
-$44.38
MARKET CAP 
70.116 M
YIELD 
N/A
SHARES OUTSTANDING 
13.330 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/24/2024
BETA 
0.76
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$246,558
AVERAGE 30 VOLUME 
$156,780
Company detail
CEO: Robert A. Berman
Region: US
Website: envveno.com
Employees: 30
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

enVVeno Medical Corporation focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the. treatment of severe deep venous chronic venous insufficiency.

Recent news